These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30154643)

  • 1. Erratum: Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum].
    Clin Ophthalmol; 2018; 12():1471. PubMed ID: 30154643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications.
    Shen J; Goodkin ML; Tong W; Attar M
    Clin Ophthalmol; 2017; 11():1761-1767. PubMed ID: 29026287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
    Brandt JD; VanDenburgh AM; Chen K; Whitcup SM;
    Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.
    Whitcup SM; Cantor LB; VanDenburgh AM; Chen K
    Br J Ophthalmol; 2003 Jan; 87(1):57-62. PubMed ID: 12488264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
    Sherwood M; Brandt J;
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S361-8. PubMed ID: 11434939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum.
    Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum].
    Clin Ophthalmol; 2018; 12():913. PubMed ID: 29845978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
    Coleman AL; Lerner F; Bernstein P; Whitcup SM
    Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.
    Laibovitz RA; VanDenburgh AM; Felix C; David R; Batoosingh A; Rosenthal A; Cheetham J
    Arch Ophthalmol; 2001 Jul; 119(7):994-1000. PubMed ID: 11448321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.
    Shedden A; Laurence J; Tipping R;
    Clin Ther; 2001 Mar; 23(3):440-50. PubMed ID: 11318078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues.
    Seal JR; Robinson MR; Burke J; Bejanian M; Coote M; Attar M
    J Ocul Pharmacol Ther; 2019; 35(1):50-57. PubMed ID: 30335560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Success of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations [Corrigendum].
    Clin Ophthalmol; 2017; 11():329. PubMed ID: 28243055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum].
    Clin Ophthalmol; 2017; 11():887. PubMed ID: 28546739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
    Bartoe JT; Davidson HJ; Horton MT; Jung Y; Brightman AH
    Vet Ophthalmol; 2005; 8(4):247-52. PubMed ID: 16008704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
    Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
    Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum.
    Clin Pharmacol; 2018; 10():71. PubMed ID: 29928148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
    Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
    J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.